ReviewMolecules (Basel, Switzerland)2012
Chiroptical switches: applications in sensing and catalysis.
Review in Molecules (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- [2.2]Paracyclophane-dicyanorhodanine conjugates as planar chiral molecular photoswitches.Organic chemistry frontiers : an international journal of organic chemistry · 2026Article
- A Bis-Perylene Diimide Macrocycle Chiroptical Switch.Angewandte Chemie (International ed. in English) · 2025Article
- Chiroptical Strain Sensors from Electrospun Cadmium Sulfide Quantum-Dot Fibers.ACS applied materials & interfaces · 2024Article
- Acid/Base-Triggered Photophysical and Chiroptical Switching in a Series of Helicenoid Compounds.Molecules (Basel, Switzerland) · 2023Article
- Inducing a pH-dependent conformational response by competitive binding to ZnChemical science · 2022Article
- Induced axial chirality by a tight belt: naphthalene chromophores fixed in a 2,5-substituted cofacialJournal of materials chemistry. C · 2021Article
- A Family of Superhelicenes: Easily Tunable, Chiral Nanographenes by Merging Helicity with Planar π Systems.Angewandte Chemie (International ed. in English) · 2021Article
- Combined reversible switching of ECD and quenching of CPL with chiral fluorescent macrocycles.Chemical science · 2018Article
- Reconfigurable, graphene-coated, chalcogenide nanowires with a sub-10-nm enantioselective sorting capability.Microsystems & nanoengineering · 2018Article
- Steric and Stereochemical Modulation in Pyridyl- and Quinolyl-Containing Ligands.Molecules (Basel, Switzerland) · 2016Review
- Conformational changes and chiroptical switching of enantiopure bis-helicenic terpyridine upon Zn(2+) binding.Chemical communications (Cambridge, England) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiroptical switches have found application in the detection of a multitude of different analytes with a high level of sensitivity and in asymmetric catalysis to offer switchable stereoselectivity. A wide range of scaffolds have been employed that respond to metals, small molecules, anions and other analytes. Not only have chiroptical systems been used to detect the presence of analytes, but also other properties such as oxidation state and other physical phenomena that influence helicity and conformation of molecules and materials. Moreover, the tunable responses of many such chiroptical switches enable them to be used in the controlled production of either enantiomer or diastereomer at will in many important organic reactions from a single chiral catalyst through selective use of a low-cost inducer: Co-catalysts (guests), metal ions, counter ions or anions, redox agents or electrochemical potential, solvents, mechanical forces, temperature or electromagnetic radiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.